393 related articles for article (PubMed ID: 10594030)
1. Regulation of a senescence checkpoint response by the E2F1 transcription factor and p14(ARF) tumor suppressor.
Dimri GP; Itahana K; Acosta M; Campisi J
Mol Cell Biol; 2000 Jan; 20(1):273-85. PubMed ID: 10594030
[TBL] [Abstract][Full Text] [Related]
2. Induction of apoptosis in human esophageal cancer cells by sequential transfer of the wild-type p53 and E2F-1 genes: involvement of p53 accumulation via ARF-mediated MDM2 down-regulation.
Itoshima T; Fujiwara T; Waku T; Shao J; Kataoka M; Yarbrough WG; Liu TJ; Roth JA; Tanaka N; Kodama M
Clin Cancer Res; 2000 Jul; 6(7):2851-9. PubMed ID: 10914734
[TBL] [Abstract][Full Text] [Related]
3. The helix-loop-helix protein Id-1 and a retinoblastoma protein binding mutant of SV40 T antigen synergize to reactivate DNA synthesis in senescent human fibroblasts.
Hara E; Uzman JA; Dimri GP; Nehlin JO; Testori A; Campisi J
Dev Genet; 1996; 18(2):161-72. PubMed ID: 8934878
[TBL] [Abstract][Full Text] [Related]
4. p14(ARF) regulates E2F activity.
Mason SL; Loughran O; La Thangue NB
Oncogene; 2002 Jun; 21(27):4220-30. PubMed ID: 12082609
[TBL] [Abstract][Full Text] [Related]
5. Differential regulation of E2F1, DP1, and the E2F1/DP1 complex by ARF.
Datta A; Nag A; Raychaudhuri P
Mol Cell Biol; 2002 Dec; 22(24):8398-408. PubMed ID: 12446760
[TBL] [Abstract][Full Text] [Related]
6. Activation of ARF by oncogenic stress in mouse fibroblasts is independent of E2F1 and E2F2.
Palmero I; Murga M; Zubiaga A; Serrano M
Oncogene; 2002 May; 21(19):2939-47. PubMed ID: 12082524
[TBL] [Abstract][Full Text] [Related]
7. Melanin accumulation accelerates melanocyte senescence by a mechanism involving p16INK4a/CDK4/pRB and E2F1.
Bandyopadhyay D; Medrano EE
Ann N Y Acad Sci; 2000 Jun; 908():71-84. PubMed ID: 10911949
[TBL] [Abstract][Full Text] [Related]
8. Regulation of two E2F-related genes in presenescent and senescent human fibroblasts.
Dimri GP; Hara E; Campisi J
J Biol Chem; 1994 Jun; 269(23):16180-6. PubMed ID: 8206919
[TBL] [Abstract][Full Text] [Related]
9. Replicative senescence, aging and growth-regulatory transcription factors.
Dimri GP; Testori A; Acosta M; Campisi J
Biol Signals; 1996; 5(3):154-62. PubMed ID: 8864060
[TBL] [Abstract][Full Text] [Related]
10. Human ARF binds E2F1 and inhibits its transcriptional activity.
Eymin B; Karayan L; Séité P; Brambilla C; Brambilla E; Larsen CJ; Gazzéri S
Oncogene; 2001 Mar; 20(9):1033-41. PubMed ID: 11314038
[TBL] [Abstract][Full Text] [Related]
11. Role of INK4a/Arf locus-encoded senescent checkpoints activated in normal and psoriatic keratinocytes.
Chaturvedi V; Cesnjaj M; Bacon P; Panella J; Choubey D; Diaz MO; Nickoloff BJ
Am J Pathol; 2003 Jan; 162(1):161-70. PubMed ID: 12507899
[TBL] [Abstract][Full Text] [Related]
12. p14ARF inhibits the growth of p53 deficient cells in a cell-specific manner.
Li Y; He L; Bruce A; Parihar K; Ingram A; Liu L; Tang D
Biochim Biophys Acta; 2006 Aug; 1763(8):787-96. PubMed ID: 16764954
[TBL] [Abstract][Full Text] [Related]
13. Activation of a cAMP pathway and induction of melanogenesis correlate with association of p16(INK4) and p27(KIP1) to CDKs, loss of E2F-binding activity, and premature senescence of human melanocytes.
Haddad MM; Xu W; Schwahn DJ; Liao F; Medrano EE
Exp Cell Res; 1999 Dec; 253(2):561-72. PubMed ID: 10585280
[TBL] [Abstract][Full Text] [Related]
14. ARF directly binds DP1: interaction with DP1 coincides with the G1 arrest function of ARF.
Datta A; Sen J; Hagen J; Korgaonkar CK; Caffrey M; Quelle DE; Hughes DE; Ackerson TJ; Costa RH; Raychaudhuri P
Mol Cell Biol; 2005 Sep; 25(18):8024-36. PubMed ID: 16135794
[TBL] [Abstract][Full Text] [Related]
15. Loss of p19(ARF) eliminates the requirement for the pRB-binding motif in simian virus 40 large T antigen-mediated transformation.
Chao HH; Buchmann AM; DeCaprio JA
Mol Cell Biol; 2000 Oct; 20(20):7624-33. PubMed ID: 11003658
[TBL] [Abstract][Full Text] [Related]
16. Senescence bypass screen identifies TBX2, which represses Cdkn2a (p19(ARF)) and is amplified in a subset of human breast cancers.
Jacobs JJ; Keblusek P; Robanus-Maandag E; Kristel P; Lingbeek M; Nederlof PM; van Welsem T; van de Vijver MJ; Koh EY; Daley GQ; van Lohuizen M
Nat Genet; 2000 Nov; 26(3):291-9. PubMed ID: 11062467
[TBL] [Abstract][Full Text] [Related]
17. p19ARF targets certain E2F species for degradation.
Martelli F; Hamilton T; Silver DP; Sharpless NE; Bardeesy N; Rokas M; DePinho RA; Livingston DM; Grossman SR
Proc Natl Acad Sci U S A; 2001 Apr; 98(8):4455-60. PubMed ID: 11274364
[TBL] [Abstract][Full Text] [Related]
18. The TFDP1 gene coding for DP1, the heterodimeric partner of the transcription factor E2F, is a target of deregulated E2F.
Nakajima R; Deguchi R; Komori H; Zhao L; Zhou Y; Shirasawa M; Angelina A; Goto Y; Tohjo F; Nakahashi K; Nakata K; Iwanaga R; Bradford AP; Araki K; Warita T; Ohtani K
Biochem Biophys Res Commun; 2023 Jun; 663():154-162. PubMed ID: 37141667
[TBL] [Abstract][Full Text] [Related]
19. A role for E2F1 in the induction of ARF, p53, and apoptosis during thymic negative selection.
Zhu JW; DeRyckere D; Li FX; Wan YY; DeGregori J
Cell Growth Differ; 1999 Dec; 10(12):829-38. PubMed ID: 10616908
[TBL] [Abstract][Full Text] [Related]
20. The cellular effects of E2F overexpression.
Adams PD; Kaelin WG
Curr Top Microbiol Immunol; 1996; 208():79-93. PubMed ID: 8575214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
